Pyridam Farma's Australian Subsidiary Achieves Groundbreaking Sustainability Milestone

Historic NABERS Carbon Rating Achievement

PT Pyridam Farma Tbk (PYFA), through its Australian subsidiary Probiotec, has made significant strides in sustainability by being part of Australia's first industrial project to receive the prestigious NABERS Embodied Carbon Rating. This achievement represents a major breakthrough in measuring and reducing carbon emissions in industrial construction.

Strengthening ESG Commitment

The NABERS rating specifically measures carbon emissions embedded in building materials and construction processes, setting a new industry benchmark for low-carbon development. This accomplishment reinforces PYFA Group's dedication to Environmental, Social, and Governance (ESG) practices that are increasingly aligned with global standards and investor expectations.

Strategic Implications for PYFA

This sustainability achievement not only enhances Probiotec's operational excellence but also strengthens PYFA's market position in the pharmaceutical industry. The commitment to ESG practices is particularly significant as global investors place greater emphasis on sustainability performance when making investment decisions.

Industry Context and Future Outlook

The recognition by NABERS marks a significant step forward in industrial sustainability practices. As the pharmaceutical industry continues to face growing scrutiny over environmental impact, PYFA's achievement positions the company favorably in the global market. The company's proactive approach to sustainability is likely to drive industry-wide changes and set new standards for corporate environmental responsibility.